X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (837) 837
Book Review (88) 88
Publication (54) 54
Conference Proceeding (12) 12
Book / eBook (9) 9
Patent (8) 8
Book Chapter (6) 6
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (264) 264
animals (262) 262
humans (233) 233
female (212) 212
male (208) 208
parasitology (136) 136
veterinary sciences (120) 120
surgery (118) 118
cattle (114) 114
adult (98) 98
feces - parasitology (75) 75
middle aged (75) 75
abridged index medicus (64) 64
infections (59) 59
aged (58) 58
prevalence (48) 48
cattle diseases - parasitology (47) 47
research (46) 46
retrospective studies (44) 44
treatment outcome (43) 43
critical care medicine (42) 42
adolescent (40) 40
analysis (40) 40
tropical medicine (40) 40
child (38) 38
diagnosis (38) 38
mortality (38) 38
sheep (38) 38
anthelmintics - therapeutic use (35) 35
ostertagiasis - veterinary (33) 33
time factors (33) 33
biochemistry & molecular biology (32) 32
pharmacology & pharmacy (32) 32
epidemiology (31) 31
risk factors (31) 31
health aspects (29) 29
parasites (29) 29
parasitic diseases (29) 29
rats (29) 29
immunology (28) 28
parasite egg count (28) 28
parasite egg count - veterinary (28) 28
biology and life sciences (27) 27
management (27) 27
research article (27) 27
young adult (27) 27
medicine and health sciences (26) 26
studies (26) 26
mice (25) 25
trauma (25) 25
usage (25) 25
calves (24) 24
efficacy (24) 24
medicine (24) 24
nematode infections - veterinary (24) 24
public health (24) 24
child, preschool (23) 23
pregnancy (23) 23
sensitivity and specificity (23) 23
infectious diseases (22) 22
physiological aspects (22) 22
proteins (22) 22
cattle diseases - epidemiology (21) 21
cattle diseases - prevention & control (21) 21
clinical neurology (21) 21
haemonchus-contortus (21) 21
nematodes (21) 21
ostertagia ostertagi (21) 21
belgium (20) 20
molecular sequence data (20) 20
prospective studies (20) 20
resistance (20) 20
tropical diseases (20) 20
veterinary medicine (20) 20
arctic medicine. tropical medicine (19) 19
care and treatment (19) 19
cattle diseases - immunology (19) 19
children (19) 19
eggs (19) 19
injury severity score (19) 19
multidisciplinary sciences (19) 19
public, environmental & occupational health (19) 19
trauma centers (19) 19
wounds and injuries - mortality (19) 19
enzyme-linked immunosorbent assay - veterinary (18) 18
ivermectin (18) 18
mathematics (18) 18
ostertagia - immunology (18) 18
public aspects of medicine (18) 18
swine (18) 18
albendazole (17) 17
cells (17) 17
gastrointestinal nematodes (17) 17
gene expression (17) 17
gene-expression (17) 17
medicine & public health (17) 17
outcomes (17) 17
patients (17) 17
anthelmintic resistance (16) 16
article (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UTL at Downsview - May be requested (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (786) 786
Dutch (65) 65
French (45) 45
German (17) 17
Italian (4) 4
Latin (2) 2
Portuguese (2) 2
Spanish (2) 2
Chinese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2008, Volume 359, Issue 21, pp. 2195 - 2207
In this trial, 17,802 healthy men and women with low-density lipoprotein cholesterol levels of less than 130 mg per deciliter and high-sensitivity C-reactive... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | APPARENTLY HEALTHY-MEN | STATIN THERAPY | INFLAMMATION | CARDIOVASCULAR-DISEASE | JUPITER TRIAL | RISK | PRAVASTATIN | CORONARY-HEART-DISEASE | PREDICTION | Myocardial Infarction - epidemiology | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | C-Reactive Protein - metabolism | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Stroke - epidemiology | Muscular Diseases - chemically induced | Stroke - prevention & control | Double-Blind Method | Kaplan-Meier Estimate | Proportional Hazards Models | Rosuvastatin Calcium | Biomarkers - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Diabetes Mellitus - chemically induced | Aged | Fluorobenzenes - adverse effects | Myocardial Infarction - prevention & control | Fluorobenzenes - therapeutic use | Prevention | Usage | C-reactive protein | Rosuvastatin | Cardiovascular diseases | Drug therapy | Health aspects | Proteins | Cardiovascular disease | Heart attacks | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 12/2013, Volume 67, Issue 12, pp. 1267 - 1282
Summary Aims Canagliflozin is a sodium glucose co‐transporter 2 inhibitor developed for the treatment of type 2 diabetes mellitus (T2DM). This randomised,... 
BODY-WEIGHT | MEDICINE, GENERAL & INTERNAL | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | GLYCEMIC CONTROL | PLACEBO | ADD-ON | DAPAGLIFLOZIN | DOUBLE-BLIND | 2 SGLT2 INHIBITOR | IMPROVES INDEXES | BETA-CELL FUNCTION | Thiophenes - adverse effects | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Weight Loss - drug effects | Metformin - adverse effects | Dose-Response Relationship, Drug | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Glucosides - adverse effects | Insulin-Secreting Cells - physiology | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Sulfonylurea Compounds - adverse effects | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin | Glucosides - administration & dosage | Adolescent | Lipid Metabolism - drug effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Glucose metabolism | Care and treatment | Clinical trials | Hypoglycemic agents | Glucose | Cholesterol | Dextrose | Diabetes therapy | Patient safety | Pharmacology | Diabetes | Drug therapy | Clinical outcomes | Endocrinology
Journal Article
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 05/2014, Volume 111, Issue 20, pp. E2100 - E2109
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2004, Volume 101, Issue 14, pp. 5146 - 5151
Journal Article
Diabetes obesity & metabolism, ISSN 1462-8902, 01/2016, Volume 18, Issue 1, pp. 82 - 91
Journal Article